Researchers
Back Away from Human Embryo Destruction
By Susan Jones
CNSNews.com Morning Editor
January 18, 2002
(CNSNews.com)
- A Virginia research laboratory involved in stem cell research has
decided to stop creating human embryos for the specific purpose of killing
them.
Over the
summer, the Jones Institute for Reproduce Medicine in Norfolk (a division
of the Eastern Virginia Medical School) created an uproar in pro-life
circles by announcing it would recruit and pay human egg donors for
the sole purpose of creating embryos that would then be destroyed in
the process of harvesting their stem cells.
The embryo
production was paid for with private money, but even so, protests followed
the announcement.
As CNSNews.com
reported last July, pro-life groups, including the National Pro-Life
Religious Council, condemned the practice of creating and manipulating
human embryos in "the strongest possible terms."
The Rev.
Rob Schenck, president of the NPRC, called the practice "absolutely
Hitleresque."
'Contentious'
policy
On Thursday,
the Jones Institute did an about-face, saying it would find other ways
to produce stem cells.
"We
are not ceasing our intent to study stem cells," said William Gibbons,
chairman of the obstetrics and gynecology department at Eastern Virginia
Medical School. "But we're not going to continue to pursue the
approach of using stem cell donors recruited to produce eggs."
The Washington
Post quoted Gibbons as saying that political pressure played a part
in the decision to stop harvesting stem cells from human embryos. "The
uproar was part of it," he's quoted as saying. The uproar included
protests as well as angry letters and emails.
Gibbons admitted
that the policy was "contentious."
It was so
contentious, in fact, that one Virginia lawmaker introduced a bill outlawing
the creation of embryos for the purpose of harvesting their stem cells.
Other research clinics, rather than creating their own human embryos,
use fertility clinic "leftovers."
Gibbons said
the Jones Institute will continue its research using stem cells derived
from umbilical cords and from adults instead of from human embryos.
|